These results provide valuable insights into the role of SLC7A11 in modulating immune responses within the tumor microenvironment, highlighting its potential as a therapeutic target for enhancing anti-tumor immunity in HNSCC (Dai et al., 2020). Here, SLC7A11 is linked to neoplasm.